Literature DB >> 16013945

[Dosage of drugs for cerebrospinal administration].

G Gil Luján1, S Clemente Bautista, M Oliveras Arenas, M J Cabañas Poy, E Hidalgo Albert.   

Abstract

OBJECTIVE: To review the most appropriate doses and routes within cerebrospinal - intrathecal, intraventricular, epidural - administration for drugs most commonly used in daily practice as reported in the literature, with particular emphasis on pediatric use.
METHOD: A systematic, sequential, repetitive search of tertiary sources primarily and then primary sources in MEDLINE (Pubmed) and GOOGLE by combining each individual drug name with "intrathecal OR intraventricular OR epidural", and then differentiating between data referring to the pediatric and adult populations.
RESULTS: In all, 28 drugs within 5 groups are described: anti-infectious, analgesic, and anti-neoplastic agents, corticoids, and other. Doses are categorized by population type: pediatric (newborns, infants, children) and adult.
CONCLUSIONS: The relevance of this administration route and its potential use do not correlate with its scant reporting in the literature, except for anti-infectious, analgesic and cytostatic agents. Only five of these drug types are officially approved for cerebrospinal administration according to their prescribing information (polymyxin B, colistin, cytarabine, baclofen and morphine). Of these, only polymyxin B and colistin are indicated for the whole of the pediatric population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013945     DOI: 10.1016/s1130-6343(05)73661-8

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  2 in total

1.  Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.

Authors:  Raquel Olmos-Jiménez; María Sacramento Díaz-Carrasco; Ana Galera-Miñarro; Juan Francisco Pascual-Gazquez; Alberto Espuny-Miró
Journal:  Int J Clin Pharm       Date:  2016-12-08

Review 2.  Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors.

Authors:  Silvia Triarico; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà; Michele Antonio Capozza; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2019-06-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.